Schonfeld Strategic Advisors LLC Applied Therapeutics Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 4,673,613 shares of APLT stock, worth $1.87 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,673,613
Previous 8,762,291
46.66%
Holding current value
$1.87 Million
Previous $7.45 Million
69.25%
% of portfolio
0.02%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding APLT
# of Institutions
97Shares Held
112MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.6 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.51 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$4.15 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$3.12 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.63 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $19.2M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...